Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis
Clinical trial NCT00035997 · COMPLETED
Trial details
- NCT number
- NCT00035997
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-04-01
- Primary completion
- 2004-01-01
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.